» Articles » PMID: 19739252

Up-regulation of Oligodendrocyte Precursor Cell AlphaV Integrin and Its Extracellular Ligands During Central Nervous System Remyelination

Overview
Journal J Neurosci Res
Specialty Neurology
Date 2009 Sep 10
PMID 19739252
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

To determine the role of extracellular matrix molecules and their integrin ligands in CNS remyelination, we have examined in experimentally induced focal demyelinated lesions the expression of the two classes of integrins implicated in oligodendrocyte development and myelination: alpha6 laminin-binding integrins and alphaV integrins that bind a range of extracellular matrix proteins containing the -Arg-Gly-Asp- (RGD) recognition sequence. Only alphaV integrins were up-regulated during remyelination, being expressed on oligodendrocyte precursor cells during their recruitment into the lesion. Next, therefore, we examined the expression of extracellular matrix ligands for alphaV integrins and documented increased expression of tenascin-C, tenascin-R, fibronectin, and vitronectin. Taken together with our previous discovery of high levels of expression of another alphaV ligand, osteopontin, during remyelination in these lesions, our findings suggest that alphaV integrins make an important contribution to successful repair in the CNS.

Citing Articles

The role of fibronectin in multiple sclerosis and the effect of drug delivery across the blood-brain barrier.

Wei S, Chen L, Yang F, Wang S, Wang P Neural Regen Res. 2023; 18(10):2147-2155.

PMID: 37056122 PMC: 10328269. DOI: 10.4103/1673-5374.369102.


Poly-L-ornithine blocks the inhibitory effects of fibronectin on oligodendrocyte differentiation and promotes myelin repair.

Xiong Y, Soomro S, Huang Z, Yu P, Ping J, Fu H Neural Regen Res. 2022; 18(4):832-839.

PMID: 36204851 PMC: 9700116. DOI: 10.4103/1673-5374.353493.


The molecular regulation of oligodendrocyte development and CNS myelination by ECM proteins.

Yamada M, Iwase M, Sasaki B, Suzuki N Front Cell Dev Biol. 2022; 10:952135.

PMID: 36147746 PMC: 9488109. DOI: 10.3389/fcell.2022.952135.


CAQK, a peptide associating with extracellular matrix components targets sites of demyelinating injuries.

Abi-Ghanem C, Jonnalagadda D, Chun J, Kihara Y, Ranscht B Front Cell Neurosci. 2022; 16:908401.

PMID: 36072569 PMC: 9441496. DOI: 10.3389/fncel.2022.908401.


Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery.

van Schaik P, Zuhorn I, Baron W Int J Mol Sci. 2022; 23(15).

PMID: 35955549 PMC: 9368816. DOI: 10.3390/ijms23158418.